跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 317 条关于
“Chengdu MaxVax”
全部
317
临床试验
57
药物
178
机构
41
资讯
41
去年
World's First Vaccine Adjuvant Library Launches to Accelerate Pandemic Preparedness
8年前
Sanofi Establishes €66 Million Global R&D Hub in Chengdu, Expanding China Research Footprint
去年
WuXi Biologics Breaks Ground on China's First Dual-Chamber Lyophilization Manufacturing Site in Chengdu
去年
Chengdu UCELLO Biotech's UC101 Becomes First Allogeneic Universal CAR-T Therapy to Receive FDA IND Approval
去年
Dual-Payload ADCs Enter Clinical Testing as Innovent and Chengdu Kanghong Pioneer Next-Generation Cancer Therapeutics
去年
Regulatory Setbacks for PTC's Translarna, Eisai/Biogen's Leqembi; Novartis Licenses Cancer Drug from Chengdu Baiyu
11个月前
Biokin Pharmaceutical Receives NMPA Approval for First-in-Class Radiopharmaceutical [177Lu]-BL-ARC001
5个月前
Chinese CDMO Facilities Achieve Major Manufacturing Milestones as Biologics Production Capacity Expands
去年
WuXi Biologics Partners with Virogen to Advance First-in-Class Anti-CD3 Immunotoxin VG712 Toward Commercial Manufacturing
4个月前
FDA Clears Gene Therapy KHN921 for Hypertrophic Cardiomyopathy Phase I/II Trial
第 1 页,共 5 页
上一页
下一页